Skip to main content

ADVERTISEMENT

oncology medicine

Research in Review
07/13/2016
JCP Editors
Findings from a single-center analysis have shown that anthracycline-based therapies may produce better outcomes in patients age 80 years and older with diffuse large B-cell lymphoma (DLBCL), supporting data reported...
Findings from a single-center analysis have shown that anthracycline-based therapies may produce better outcomes in patients age 80 years and older with diffuse large B-cell lymphoma (DLBCL), supporting data reported...
...
07/13/2016
Journal of Clinical Pathways